Scarica l'app Stockscreener
0.9515
9.66%
0.0838
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TLRY Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.8677
Aprire:
$0.87
Volume 24 ore:
81.08M
Relative Volume:
2.00
Capitalizzazione di mercato:
$888.67M
Reddito:
$829.22M
Utile/perdita netta:
$-248.96M
Rapporto P/E:
-3.1717
EPS:
-0.3
Flusso di cassa netto:
$-92.10M
1 W Prestazione:
+2.00%
1M Prestazione:
-18.68%
6M Prestazione:
-49.66%
1 anno Prestazione:
-46.54%
Intervallo 1D:
$0.8251
$1.03
Intervallo di 1 settimana:
$0.8251
$1.03
Portata 52W:
$0.8251
$2.97
Tilray Brands Inc Stock (TLRY) Company Profile
Nome
Tilray Brands Inc
Settore
Telefono
519.322.8800
Indirizzo
655 MADISON AVENUE, NEW YORK
Confronta TLRY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
0.9515 | 888.67M | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-05 | Reiterato | Alliance Global Partners | Neutral |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-29 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Iniziato | Barclays | Underweight |
| 2021-11-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Ripresa | Cowen | Outperform |
| 2021-05-07 | Ripresa | Jefferies | Buy |
| 2021-05-06 | Iniziato | Canaccord Genuity | Buy |
| 2021-04-28 | Ripresa | BofA Securities | Buy |
| 2021-02-18 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-11-11 | Downgrade | Stifel | Hold → Sell |
| 2020-10-01 | Reiterato | MKM Partners | Neutral |
| 2020-09-21 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-05-12 | Reiterato | The Benchmark Company | Buy |
| 2020-04-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-04-09 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-13 | Iniziato | BofA/Merrill | Neutral |
| 2019-11-13 | Reiterato | The Benchmark Company | Buy |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Reiterato | Piper Jaffray | Overweight |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-08-14 | Reiterato | The Benchmark Company | Buy |
| 2019-07-17 | Iniziato | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Iniziato | Consumer Edge Research | Overweight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Iniziato | Oppenheimer | Perform |
| 2019-05-15 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Iniziato | Alliance Global Partners | Neutral |
Mostra tutto
Tilray Brands Inc Borsa (TLRY) Ultime notizie
Tilray Brands Inc. stock rises Friday, outperforms market - MarketWatch
Tilray (TLRY): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors - Yahoo Finance
Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs - GlobeNewswire
Delaware court frees former Tilray partners from $13M Marley licensing fee - Green Market Report
12 Best Get Rich Fast Stocks To Buy Now - Insider Monkey
Is Tilray Brands, Inc. (TLRY) the Best Get Rich Fast Stock to Buy Now? - Insider Monkey
Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs -February 20, 2025 at 08:03 am EST - Marketscreener.com
Tilray Brands Inc. stock falls Wednesday, underperforms market - MarketWatch
Tilray Brands, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know - MSN
Tilray Brands Inc. stock falls Tuesday, underperforms market - MarketWatch
Looking Into Tilray Brands's Recent Short Interest - Benzinga
Tilray stock touches 52-week low at $0.9 amid market challenges - Investing.com India
Decibel Expands General Admission Brand's International Footprint - Cannabis Business Times
HYTN, A1 Cannabis Partner to Scale Production of Cannabis Products - Cannabis Business Times
Tilray stock price crashes below $1: buy the dip or sell the rip? - MSN
Tilray (NASDAQ:TLRY) Trading Down 0.1%What's Next? - MarketBeat
Top Cannabis Stocks To Watch TodayFebruary 17th - MarketBeat
Tilray (NASDAQ:TLRY) Trading Down 1.1%Should You Sell? - MarketBeat
Tilray (NASDAQ:TLRY) Shares Down 3.7%Here's Why - MarketBeat
Tilray: Improved Balance Sheet And Reasonable Valuation (Rating Upgrade) - Seeking Alpha
Tilray (NASDAQ:TLRY) Stock Price Down 0.5%What's Next? - MarketBeat
2 Beaten-Down Stocks to Avoid - MSN
Tilray (NASDAQ:TLRY) Stock Price Down 0.1%Here's What Happened - MarketBeat
Best Cannabis Stocks To Follow TodayFebruary 15th - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Down 3.7%What's Next? - MarketBeat
Top Cannabis Stocks To ConsiderFebruary 13th - MarketBeat
Tilray Brands Inc. stock falls Friday, underperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Trading Down 4%What's Next? - MarketBeat
Best Cannabis Stocks To ConsiderFebruary 14th - MarketBeat
Tilray Brands, Inc. (TLRY) Ascends While Market Falls: Some Facts to Note - MSN
Cannabis Stocks To ResearchFebruary 12th - MarketBeat
StockTalk | Cannabis Report: Vapes, ketamine, and celebrity endorsements | 2025-02-14 | Investing News - Stockhouse Publishing
Tilray (NASDAQ:TLRY) Trading Down 5.2%Time to Sell? - MarketBeat
Tilray Brands Inc. stock rises Wednesday, outperforms market - MarketWatch
Tilray Ceases Large-Scale Production at Revolver; Taproom Remains Open - Brewbound.com
Tilray Medical Expands Medical Cannabis Portfolio in Germany -February 11, 2025 at 07:00 am EST - Marketscreener.com
Beyond Germany: Other international markets for cannabis opportunities - Green Market Report
Tilray élargit son portefeuille de produits à base de cannabis thérapeutique en Allemagne - GlobeNewswire Inc.
Tilray stock touches 52-week low at $0.94 amid market challenges - MSN
Blue Point Brewing Announces 5th Annual Shakedown on Main Street Festival - Tilray
Tilray stock touches 52-week low at $0.94 amid market challenges By Investing.com - Investing.com South Africa
Tilray expands German medical cannabis offering | 2025-02-11 | Investing News - Stockhouse Publishing
Ultimate Summer Festival Alert: Blue Point's Shakedown Combines Craft Beer, Live Music & Local Art - StockTitan
Tilray Brief: Launching New Cannabis Extract Products And Formulations As Expands Medical Cannabis Portfolio in Germany - Marketscreener.com
Tilray Brief: Expanding Medical Cannabis Portfolio in Germany -February 11, 2025 at 07:14 am EST - Marketscreener.com
Tilray Expands Medical Cannabis Portfolio in Germany - The Manila Times
Tilray (TLRY) Launches Game-Changing THC-CBD Extracts in Europe's Largest Market - StockTitan
Cannabis Cultivation Market Is Booming Worldwide 2025-2032:Aphria, Inc, Aurora Cannabis, Tilray, Organigram - EIN News
International cannabis markets could offer better growth opportunities - Green Market Report
Tilray (TLRY) Stock Drops 5% Amidst Market Fluctuations - GuruFocus.com
Tilray Brands Inc Azioni (TLRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tilray Brands Inc Azioni (TLRY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Persofsky Renah | Director |
Nov 08 '24 |
Option Exercise |
1.50 |
11,958 |
17,937 |
75,348 |
| SIMON IRWIN D | President and CEO |
Jul 31 '24 |
Option Exercise |
2.03 |
706,214 |
1,433,614 |
3,637,021 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
703,412 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
468,218 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
583,643 |
| SIMON IRWIN D | President and CEO |
Jul 26 '24 |
Option Exercise |
1.83 |
98,194 |
179,695 |
2,985,109 |
| Merton Carl A | Chief Financial Officer |
Jul 26 '24 |
Option Exercise |
1.83 |
12,166 |
22,264 |
615,102 |
| Looney Thomas P. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
230,038 |
| Hopkinson David G. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
211,185 |
| Herhalt Johann Michael | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
180,514 |
3.23%
3.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):